NCT02500732View on ClinicalTrials.gov

Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

March 31, 2018

Conditions
Vasovagal Syncope
Interventions
DRUG

Atomoxetine

40mg PO the night before and the morning of the study tilt table test.

DRUG

Placebo

oral placebo capsule designed to blind the atomoxetine intervention

Trial Locations (1)

T2N 4Z6

University of Calgary, Calgary

All Listed Sponsors
collaborator

Cardiac Arrhythmia Network of Canada

OTHER

lead

University of Calgary

OTHER

NCT02500732 - Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope | Biotech Hunter | Biotech Hunter